BioSpace News Archive

Business

Stanford Neuroscientist Karl Deisseroth Receives Japan’s Kyoto Prize in Advanced Technology

Revolutionary discoveries bring award of 100 million yen (about US$880,000)

November 18, 2018
·
2 min read
Drug Development

Landmark PALISADE Trial of AR101 Published in New England Journal of Medicine

Treatment with AR101 significantly increased the amount of peanut protein tolerated and reduced the number and severity of reactions to peanut protein

November 18, 2018
·
13 min read
Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems

As the global leader in biosimilars, Celltrion Healthcare aims to positively shape future healthcare by improving patient access to biosimilars

November 18, 2018
·
6 min read
Biotech Bay

China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg).

November 18, 2018
·
7 min read
Drug Development

CStone initiates a bridging Phase I clinical trial for PD-1 antibody CS1003 with first patient dosed in China

CStone Pharmaceuticals (CStone) today announced that a first patient has been enrolled and dosed in a Phase I clinical trial in China for the recombinant humanized anti-programmed death-1 (PD-1) monoclonal antibody (mAb) CS1003.

November 18, 2018
·
3 min read